CVS could face long arduous turnaround like Walgreens
CVS Health's turnaround could be long and difficult amid CEO change, rising costs, and potential divestitures, while ...
BioNTech and Moderna: A tale of two mRNA developers
Discover why the stock prices of mRNA therapy creators BioNTech and Moderna have plummeted and whether they are still worth ...
BioNTech, OncoC4 Phase 3 study put on partial hold by FDA
BioNTech (BNTX) and OncoC4 have had a partial clinical hold placed by the FDA on a Phase 3 study for BNT316/ONC-392 in the ...
BioNTech shares slip as FDA places partial clinical hold on lung cancer study
BioNTech (NASDAQ: BNTX) shares fell Friday after the company said it had been informed by partner OncoC4 that FDA placed ...
The Pharma Letter1d
FDA puts partial clinical hold on gotistobart trial
BioNTech (Nasdaq: BNTX) and partner USA-based OncoC4 understand that the partial clinical hold in the ongoing Phase III trial ...
TuHURA Biosciences, Inc.: TuHURA Biosciences Completes Merger Transaction with Kintara Therapeutics
Combined company will operate as TuHURA Biosciences, Inc. and advance pipeline of novel technologies to overcome resistance to cancer immunotherapyLead program entering single Phase 3 accelerated appr ...
Moderna Hit With Another Lawsuit Related To Key COVID-19 Vaccine Technology
Northwestern University has filed a lawsuit against Moderna, alleging the company used its patented lipid nanoparticle ...
Novavax's stock slides 19% after FDA puts clinical hold on COVID and flu vaccine candidates
The FDA approved the company's COVID vaccine in October 2023. The stock has gained 111% in the year to date, while the S&P 500 SPX has gained 22%. This content was created by MarketWatch, which is ...
TSMC Is the Chip Sector’s Hero. Why That’s a Risk for U.S. Tech and 5 Other Things to Know Today.
Amazon goes all-in on nuclear energy in power push, FDA pauses Novavax’s trial of Covid-flu combo vaccine, and more news to ...
Novavax shares sink as US FDA puts trial of combo COVID-flu vaccine on hold
Shares in Novavax (NASDAQ:NVAX) slumped in premarket US trading on Wednesday after the US Food and Drug Administration placed ...
US FDA pauses Novavax's trial of combo COVID-flu shot on safety concerns
Novavax's protein-based COVID vaccine is the biotech's only commercial product. The shot has failed to make a significant ...
Hosted on MSN3d
Why Autolus Therapeutics plc (AUTL) is the Penny Stock with the Biggest Upside Potential According to Analysts
Autolus Therapeutics (NASDAQ:AUTL) is a clinical-stage biopharmaceuticals company ... This initiative includes a partnership ...